Optimal Care Pathways for lymphoma
Lymphoma is the general term for cancers that develop in the lymphatic system. The lymphatic system is made up of a vast network of vessels (similar to blood vessels) that branch out into all the tissues of the body. These vessels contain lymph, a colourless watery fluid that carries lymphocytes, which are specialised white blood cells that fight infection. There are two types of lymphocytes, B-lymphocytes and T-lymphocytes (also called B-cells and T-cells). These cells protect us by making antibodies and destroying harmful microorganisms such as bacteria and viruses.
Disease-specific Optimal Care Pathways have been developed for the following diseases, each accompanied by a quick reference guide and patient guide, specially designed to help people in Australia with blood cancer, and their loved ones. The OCP patient guides are suitable to be shared with your patients, to ensure they are informed of their upcoming blood cancer journey.
Cutaneous T-Cell lymphoma
Comprehensive Optimal Care Pathway for Cutaneous T-Cell lymphoma Quick reference guide for the OCP for Cutaneous T-Cell lymphoma Guide to best cancer care for Cutaneous T-Cell lymphoma – suitable for sharing with your patientHodgkin and diffuse large B-cell lymphoma
Comprehensive Optimal Care Pathway for Hodgkin and diffuse large B-cell lymphoma Quick reference guide for the OCP for Hodgkin and diffuse large B-cell lymphoma Guide to best cancer care for Hodgkin and diffuse large B-cell lymphoma – suitable for sharing with your patientLow grade lymphoma – (including follicular lymphoma, marginal zone lymphoma and mantle cell lymphoma)
Comprehensive Optimal Care Pathway for low grade lymphoma Quick reference guide for the OCP for low grade lymphoma Guide to best cancer care for low grade lymphoma – suitable for sharing with your patientWaldenström’s macroglobulinaemia (WM)
Comprehensive Optimal Care Pathway for Waldenström’s macroglobulinaemia (WM) Quick reference guide for the OCP for Waldenström’s macroglobulinaemia (WM) Guide to best cancer care for Waldenström’s macroglobulinaemia (WM) – suitable for sharing with your patientOptimal Care Pathways are one of the key recommendations in Australia’s National Strategic Action Plan for Blood Cancer. They will help you, as a health professional, provide nationally consistent, high-quality, evidence-based information at each stage of the blood cancer pathway, from diagnosis and treatment to ongoing care.
Last updated on May 21st, 2024
Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.